BILLS-107hr2973ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (38)
one year
the first day
more than 8 months
annual
months
5-consecutive-year
6-month
17
year
a year
no later than 180 days
2973 IH
January
23
1, 2002
10
day
later than 90 days
1, 2002
3-year
8 months
fiscal year 2003
90 days
October 1, 2002
December 31, 2003
more than 10 months
17
quarter
2973 IH
SECTION 1
2000
the preceding year
12-month
12
day
2973 IH
year
2001
a fiscal year
10 months
OCTOBER 2, 2001
any year
1862
fiscal year
EVENT (3)
the ‘‘Medicare Innovation Responsive-
4
the ‘CMS’
SESSION
H. R. 2973
GPE (3)
2973 IH
the United States
the United States of America
NORP (1)
Cosmetic
ORG (43)
SEC
U.S.C.
the Federal Food, Drug
DRG
HCPCS
Medicare & Medicaid Services
Medicare
INTERNAL
Congress
CMS
Health
an Office of Technology and Innovation
Office of Technology and Innovation
the Centers for Medicare & Med-
the Health Care Financing
the Committee on Ways and Means
Recognition
OFFICE OF TECHNOLOGY
K)(vi)(II
9th Revision
Centers
Technology and Innovation
the Medicare Program
Human Services
Innovation
PPS
DIRECTOR.—The Office of Technology
House of Representa-
Senate
the Committee on Energy and Commerce
Centers for Medicare & Med-
THE HOUSE OF REPRESENTATIVES
the Senior Executive Service
HCPCS Level II
the Federal Food, Drug and Cosmetic Act
EXTERNAL
Medicaid
PERSON (3)
RAMSTAD
THURMAN
K)(vi
Topic Classifications
congressional legislation
97.3%
government oversight
45.7%
public health
17.8%
Extracted Keywords
coverage
innovation
determination
inpatient
determina
items services
deter mination
medicare
mination
technology
establish office
period begins
determina tion
title references
begins date
Forensic Analysis
PDF Metadata
- ModDate
- D:20230115220923Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20011004152510Z
Sentiment
Polarity
Neutral
0.001
Subjectivity
31%
Objective